- Urinary and dietary sodium and potassium associated with blood pressure control in treated hypertensive kidney transplant recipients: an observational studyAnnie Saint-Remy
Nephrology Hypertension Unit, University Hospital of Liege, Liege, Belgium
BMC Nephrol 13:121. 2012..Using an agreement between office and home BP, the present study investigated the relations between the BP control in Kt recipients and their urinary excretion and dietary consumption of sodium and potassium...
- What's new in renal and pancreatic transplantation in 2011?L Weekers
Service of Nephrology, Dialysis and Transplantation, Centre Hospitalier Universitaire, Liege, Belgium
Transplant Proc 44:2784-6. 2012..The main information drawn from these papers is summarized in this brief review...
- [Prevention of diabetic nephropathy: from microalbuminuria to end-stage renal insufficiency]L Weekers
Service de Néphrologie et de Diabétologie, Nutrition et Maladies Metaboliques, CHU Sart Tilman, Liege
Rev Med Liege 58:297-306. 2003..We briefly discuss the results of the main studies that have led to those conclusions...
- [Diabetic nephropathy]L Weekers
Service de Nephrologie, CHU Sart Tilman, Liege
Rev Med Liege 60:479-86. 2005..Among individuals with type 2 diabetes, kidney disease is often multifactorial. This paper reviews recent developments in the pathophysiology, epidemiology and treatment of diabetic nephropathy...
- Evolution of native kidney function after pancreas transplantation aloneH Le Dinh
Department of Abdominal Surgery and Transplantation, University Hospital, Liege, Belgium
Transplant Proc 44:2829-33. 2012..This study investigated changes in kidney function over time among a cohort of patients undergoing pancreas transplantation alone (PTA) from January 2002 to December 2011...
- Fluorodeoxyglucose F(18) Positron Emission Tomography Coupled With Computed Tomography in Suspected Acute Renal Allograft RejectionP Lovinfosse
Division of Nuclear Medicine, Department of Medical Physics, University of Liege Hospital, Liege, Belgium
Am J Transplant 16:310-6. 2016..93, with 100% sensitivity and 50% specificity using a mean SUV threshold of 1.6. In conclusion, (18) F-FDG PET/CT may help noninvasively prevent avoidable transplant biopsies in KTRs with suspected AR. ..
- [Arterial pulse pressure in relation to the duration of type 1 diabetes: a cross-sectional controlled study]J C Philips
Service de Diabetologie, Nutrition et Maladies Metaboliques, Departement de Medecine, CHU Sart Tilman, Universite de Liege, Belgique
Arch Mal Coeur Vaiss 99:683-6. 2006..The role of such PP rise in the increased cardiovascular risk of patients with type 1 diabetes, although suspected in the recent EURODIAB Prospective Complications Study, deserves further investigation...
- [Hypertension and diabetes]J M Krzesinski
Service de Nephrologie, CHU Sart Tilman
Rev Med Liege 60:572-7. 2005..A frequent evaluation of the cardiovascular risk is required together with research of renal dysfunction or microproteinuria...
- A more than 20% increase in deceased-donor organ procurement and transplantation activity after the use of donation after circulatory deathH Le Dinh
Department of Abdominal Surgery and Transplantation, University Hospital of Liege, Liege, Wallonia, Belgium
Transplant Proc 46:9-13. 2014....
- [Differences in glycemic balance (but not weight) correlate positively with changes in absolute cardiovascular risk in diabetic patients]S Hadjadj
, Centre Hospitalier Universitaire d'Angers
Arch Mal Coeur Vaiss 93:1033-6. 2000..008 and Rho = 0.019; NS, respectively). These results suggest that, in diabetic patients, changes in glycaemic control affect their CRP by an effect on total cholesterol, but the changes in body weight do not affect their CRP...
- [Clinical study of the month. Nephroprotective role of angiotensin II receptor antagonists in type 2 diabetes: results of the IDNT and RENAAL trials]L Weekers
, CHU Sart-Tilman
Rev Med Liege 56:723-6. 2001..This effect goes beyond the reduction in blood pressure and makes of ARA's one of the important tools in the treatment of type 2 diabetic nephropathy...
- [Clinical study of the month. The CALM study assessing the combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist in the treatment of diabetic nephropathy]J C Philips
, CHU Sart Tilman,
Rev Med Liege 56:126-8. 2001..No comparison is made between this "new" association and the more frequently used biotherapy (i.e. ACE-I plus thiazidic diuretic) and therefore its usefulness in regular practice is still to be determined...